This paper presents specific guidelines, developed by the International Society of Geriatric Oncology (SIOG), for the treatment of localized and metastatic prostate cancer, specifically in older men. Prostate cancer is predominantly a disease of older men (> 70 years). A systematic review of the literature revealed that besides the...
Read MoreCurrent PSA level-Between 4 to 10 Posts on Medivizor
Evaluating survival rates in patients with prostate cancer treated with low-dose-rate brachytherapy
In a nutshell The present study evaluated survival rates in patients with prostate cancer (PC) treated with Low-dose-rate prostate brachytherapy (LDR-PB). The main findings were that LDR-PB alone or combined with hormone therapy offers excellent survival in PC patients. Some background Prostate cancer is the most common type of cancer in men....
Read More